Delivery Order SPE2DB20D3101-SPE2DB22FK5C4
- Not listed
- This federal contract award is for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical products to the Defense Logistics Agency (DLA). The $12,995.54 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of September 12, 2024 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award is for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The $4,717.20 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 17, 2024, with a completion date of December 18, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,273.50 firm fixed-price delivery order is for TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product. The contract has an ultimate completion date of June 20, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award, issued by the Defense Logistics Agency (DLA), is for the pharmaceutical product TRELEGY ELLIPTA 200-62.5-25 60S. The $21,005.56 Firm Fixed Price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of January 8, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award is for the delivery of TRELEGY ELLIPTA 200-62.5-25 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,069.82 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on February 13, 2025, with a completion date of February 14, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award is for the procurement of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product, by the Defense Logistics Agency (DLA). The $20,893.83 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of May 15, 2024 and was not set aside for any specific business type. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award to AmerisourceBergen Drug Corp. is a Delivery Order valued at $11,683.86 for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense, and has an ultimate completion date of October 30, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle...
- This federal contract award from the Defense Logistics Agency (DLA) was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,570.32 firm fixed-price delivery order is for the supply of TRELEGY ELLIPTA 200-62.5-25 60S, a pharmaceutical product. The contract has an ultimate completion date of May 9, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award is for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $5,147.24 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on August 25, 2022, with a completion date of August 26, 2022. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,108.70 delivery order contract is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product, with a completion date of December 16, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB22FK5C4Delivery Order
This federal contract award is for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical products to the Defense Logistics Agency (DLA). The $6,999.56 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on July 29, 2022. The contract has an ultimate completion date of August 1, 2022 and was not designated with a set-aside requirement. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This particular delivery order is likely part of that broader IDC. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.0k | 7/29/22 |